fda glp-1 compounding enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA issued 25 warning letters

Thats a meaningful result

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

Grocery spending in Britain has fallen by 780m over the past two years due to the growing use of GLP-1 weight loss drugs, according to new research from Worldpanel by Numerator.

The GLP-1 Companion Bundle by DaVinci combines three doctor-formulated supplements to complement the use of wellness products intended for weight management and promote healthy weight, muscle, and metabolism.*

Compared to semaglutide alone, the combination resulted in significantly greater weight loss, better body composition, and reductions in visceral fat and inflammation